Comprehensive review of the effects of diabetes on ocular health

References

• CDC Diabetes Success and opportunities for population-based prevention and control: at a glance (2009).
   Google Scholar
• Congdon N, Freidman D, Lietman T. Important causes of visual impairment in the world today. JAMA290, 2057–2060 (2003).
   PubMed Web of Science ®Google Scholar
• Waite JH, Beetham WP. The visual mechanism in diabetes mellitus: a comprehensive study of 2002 diabetics and 457 non-diabetics for control. N. Engl. J. Med.212, 367–379 (1935).
   Google Scholar
• Rocha G, Garza G, Font RL. Orbital pathology associated with diabetes mellitus. Int. Ophthalmol. Clin.38(2), 169–179 (1998).
   PubMedGoogle Scholar
• Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am. J. Optom. Physiol. Optics.65(3), 224–230 (1988).
   PubMedGoogle Scholar
• Negi A, Vernon SA. An overview of the eye in diabetes. J. R. Soc. Med.96, 266–272 (2003).
   PubMed Web of Science ®Google Scholar
• Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans. Am. Ophthal. Soc.79, 180–199 (1981).
   PubMedGoogle Scholar
• Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N. Engl. J. Med.341(25), 1906–1912 (1999).
   PubMedGoogle Scholar
• Shah BR, Hux JE. Quantifying the risk of infectious disease for people with diabetes. Diabetes Care26(2), 510–513 (2003).
   PubMed Web of Science ®Google Scholar
• Kruse A, Thomsen RW, Hundborg HH, Knudsen LL, Sorensen HT, Schoenheyder HC. Diabetes and risk of acute infectious conjunctivitis-a population-based case–control study. Diabet. Med.23, 393–397 (2006).
   PubMed Web of Science ®Google Scholar
• Seifart U, Strempel I. The dry eye and diabetes mellitus. Ophthalmologe91(2), 235–239 (1994).
   PubMedGoogle Scholar
• Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology108, 586–592 (2001).
   PubMed Web of Science ®Google Scholar
• Yoon KC, Im SK, Seo MA. Changes in tear film and ocular surface in diabetes mellitus. Korean J. Ophthalmol.18, 168–174 (2004).
   PubMedGoogle Scholar
• Owen CG, Newsom RSB, Rudnicka AR, Barman SA, Woodward G, Ellis TJ. Diabetes and the tortuosity of vessels of the bulbar conjunctiva. Ophthalmology115, 27–32 (2008).
   PubMedGoogle Scholar
• Owen CG, Newsom RSB, Rudnicka AR, Ellis TJ, Woodward G. Vascular response of the bulbar conjunctiva to diabetes and elevated blood pressure. Ophthalmology112, 1801–1808 (2005).
   PubMed Web of Science ®Google Scholar
• Funahashi T, Fink AI. The pathology of the bulbar conjunctiva in diabetes mellitus: I. Microaneurysms. Am. J. Ophthalmol.55, 504–511 (1963).
   PubMedGoogle Scholar
• Ozdemir M, Buyukbese MA, Cetinkaya A, Ozdemir G. Risk factors for ocular surface disorders in patients with diabetes mellitus. Diabetes Res. Clin. Pract.59, 195–199 (2003).
   PubMed Web of Science ®Google Scholar
• Goebbels M. Tear secretion and tear film function in insulin dependent diabetics. Br. J. Ophthalmol.84, 19–21 (2000).
   PubMed Web of Science ®Google Scholar
• Kaiserman I, Kaiserman N, Nakar A, Vinker S. Dry eye in diabetic patients. Am. J. Ophthalmol.139, 498–503 (2005).
   PubMed Web of Science ®Google Scholar
• Riss B, Binder S. Corneal sensitivity after photocoagulation for diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol.217, 143–147 (1981).
   Google Scholar
• Saito J, Enoki M, Hara M, Morishige N, Chikama T, Nishida T. Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy. Cornea22(1), 15–18 (2003).
   PubMed Web of Science ®Google Scholar
• Nepp J, Abela C, Polzer I, Derbolav A, Wedrich A. Is there a correlation between the severity of diabetic retinopathy and keratoconjunctivitis sicca? Cornea19(4), 487–491 (2000).
   PubMed Web of Science ®Google Scholar
• Alves M, Calegari VC, Cunha DA, Saad MJ, Velloso LA, Rocha EM. Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor κ-B in lacrimal glands of diabetic rats. Diabetologia48, 2675–2681 (2005).
   PubMed Web of Science ®Google Scholar
• Inoue K, Kato S, Ohara C, Numaga J, Amano S, Oshika T. Ocular and systemic factors relevant to diabetic keratoepithliopathy. Cornea8, 798–801 (2001).
   Google Scholar
• Schultz RO, Matsuda M, Yee RW, Edelhauser HF, Schultz KJ. Corneal endothelial changes in Type I and Type II diabetes mellitus. Am. J. Ophthalmol.98(4), 401–410 (1984).
   PubMed Web of Science ®Google Scholar
• Foulks GN, Thoft RA, Perry HD, Tolentino FI. Factors related to corneal complications after closed vitrectomy in patients with diabetes. Arch. Ophthalmol.97(6), 1076–1078 (1979).
   PubMed Web of Science ®Google Scholar
• Chung H, Tolentino FI, Cajita VN, Acosta J, Refojo MF. Reevaluation of corneal complications after closed vitrectomy. Arch. Ophthalmol.106(7), 916–919 (1988).
   PubMed Web of Science ®Google Scholar
• Saini JS, Khandalavla B. Corneal epithelial fragility in diabetes mellitus. Can. J. Ophthalmol.30, 142–146 (1995).
   PubMed Web of Science ®Google Scholar
• Hatchell DL, Magolan JJ Jr, Besson MJ, Goldman AI, Pederson HJ, Shutz KJ. Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch. Ophthalmol.101(3), 469–471 (1983).
   PubMed Web of Science ®Google Scholar
• Schultz RO, Peters MA, Sobocinski K, Nassif K, Schultz KJ. Diabetic corneal neuropathy. Trans. Am. Ophthalmol. Soc.81, 107–124 (1983).
   PubMedGoogle Scholar
• Schultz RO, Peters MA, Sobocinski K, Nassif K, Schultz KJ. Diabetic keratopathy as a manifestation of peripheral neuropathy. Am. J. Ophthalmol.96, 368–371 (1983).
   PubMed Web of Science ®Google Scholar
• Schwartz DE. Corneal sensitivity in diabetics. Arch. Ophthalmol.91(3), 174–178 (1974).
   PubMed Web of Science ®Google Scholar
• Rosenberg ME, Tervo TMT, Immonen IJ, Muller LJ, Gronhagen-Riska C, Vesaluoma MH. Corneal structure and sensitivity in Type 1 diabetes mellitus. Invest. Ophthalmol. Vis. Sci.41, 2915–2921 (2000).
   PubMed Web of Science ®Google Scholar
• Hyndiuk RA, Kazarian EL, Schultz RO, Seideman S. Neurotrophic corneal ulcers in diabetes mellitus. Arch. Ophthalmol.95(12), 2193–2196 (1977).
   PubMedGoogle Scholar
• Mishima S. The effects of the denervation and stimulation of the sympathetic and the trigeminal nerve on the mitotic rate of the corneal epithelium in the rabbit. Jpn. J. Ophthalmol.1, 65–73 (1957).
   Google Scholar
• Alper MG. The anesthetic eye: an investigation of changes in the anterior ocular segment of the monkey caused by interrupting the trigeminal nerve at various levels along its course. Trans. Am. Ophthalmol. Soc.72, 323–365 (1975).
   Google Scholar
• Araki K, Ohashi Y, Kinoshita S et al. Epithelial wound healing in the denervated cornea. Curr. Eye Res.13, 203–211 (1994).
   PubMed Web of Science ®Google Scholar
• Baker KS, Anderson SC, Romanowski EG et al. Trigeminal ganglion neurons affect corneal epithelial phenotype: influence on type VII collagen expression in vitro. Invest. Ophthalmol. Vis. Sci.34, 137–144 (1993).
   PubMed Web of Science ®Google Scholar
• Xu KP, Li Y, Ljubimov AV, Yu FS. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes58(5), 1077–1085 (2009).
   PubMed Web of Science ®Google Scholar
• Kenyon K, Wafai Z, Michels R, Conway B, Tolento F. Corneal basement membrane abnormality in diabetes mellitus (ARVO ABSTRACT). Invest. Ophthalmol. Vis. Sci.17(4), S245 (1978) (Abstract 1).
   Google Scholar
• Foulks GN, Thoft RA, Perry HD, Tolentino FI. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch. Ophthalmol.97(6), 1076–1078 (1979).
   PubMed Web of Science ®Google Scholar
• Perry HD, Foulks GN, Thoft RA, Tolentino FI. Corneal complications following closed vitrectomy through the pars plana. Arch. Ophthalmol.96(8), 1401–1403 (1978).
   PubMed Web of Science ®Google Scholar
• Brightbill FS, Myers FL, Bresnick GH. Postvitrectomy keratopathy. Am. J. Ophthalmol.85, 651–655 (1978).
   PubMed Web of Science ®Google Scholar
• Mendelcorn MS, Blankenship G, Machemer R. Pars plana vitrectomy for the management of severe diabetic retinopathy. Am. J. Ophthalmol.81, 561–570 (1976).
   PubMedGoogle Scholar
• Kaji Y, Usui T, Oshika T et al. Advanced glycation end products in diabetic corneas. Invest. Ophthalmol. Vis. Sci.41, 362–368 (2000).
   PubMed Web of Science ®Google Scholar
• Ljubimov AV, Huang Z, Huang GH et al. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J. Histochem. Cytochem.46, 1033–1041 (1998).
   PubMed Web of Science ®Google Scholar
• Gekka M, Miyata K, Nagai Y et al. Corneal epithelial barrier function in diabetic patients. Cornea23(1), 35–37 (2004).
   PubMed Web of Science ®Google Scholar
• Goebbels M, Spitznas M, Oldendoerp J. Impairment of corneal epithelial barrier function in diabetics. Graefes Arch. Clin. Exp. Ophthalmol.227, 142–144 (1989).
   PubMedGoogle Scholar
• Alfonso EC, Rosa RH Jr. Fungal keratitis. In: Cornea. Krachmer JH, Mannis MJ, Holland HJ (Eds). Mosby, St. Louis, MO, USA, 1253–1265 (1997).
   Google Scholar
• Gapinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao G. The epidemiological features and laboratory results of fungal keratitis. Cornea21(6), 555–559 (2002).
   PubMedGoogle Scholar
• Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J. Ophthalmol.51(4), 315–321 (2003).
   PubMedGoogle Scholar
• Busted N, Olsen T, Schmitz O. Clinical observations on the corneal thickness and the corneal endothelium in diabetes mellitus. Br. J. Ophthalmol.65, 687–690 (1981).
   PubMed Web of Science ®Google Scholar
• Su DHW, Wong TY, Wong W et al. Diabetes, hyperglycemia, and central corneal thickness. Ophthalmology115(6), 964–968 (2008).
   PubMed Web of Science ®Google Scholar
• Saini JS, Mital S. In vivo assessment of corneal endothelial function in diabetes mellitus. Arch. Ophthalmol.114(6), 649–653 (1996).
   PubMed Web of Science ®Google Scholar
• Lee JS, Oum BS, Choi HY, Lee JE, Cho BM. Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye20, 315–318 (2006).
   PubMed Web of Science ®Google Scholar
• Rubenstein MP. Diabetes, the anterior segment and contact lens wear. Contact Lens J.15, 4–11 (1987).
   Google Scholar
• Henkind P, Wise GN. Decemet’s wrinkles in diabetes. Am. J. Ophthalmol.52, 371–374 (1961).
   PubMed Web of Science ®Google Scholar
• Fraufelder FW, Rich LF. Laser-assisted in situ keratomileusis complications in diabetes mellitus. Cornea21(3), 246–248 (2002).
   PubMedGoogle Scholar
• Gimbel HV, van Westenbrugge JA, Anderson Penno EE et al. Simultaneous bilateral laser in situ keratomileusis: safety and efficacy. Ophthalmology106, 1461–1467 (1999).
   PubMed Web of Science ®Google Scholar
• Wang MY, Maloney RK. Epithelial ingrowth after laser in situ keratomileusis for the correction of myopia. Am. J. Ophthalmol.129, 746–751 (2000).
   PubMed Web of Science ®Google Scholar
• Stulting RD, Carr JD, Thompson KP, Waring GO III, Wiley WM, Walker JG. Complications of laser in situ keratomileusis for the correction of myopia. Ophthalmology106(1), 13–20 (1999).
   PubMed Web of Science ®Google Scholar
• Jabbur NS, Chicani CF, Kuo IC, O’Brien TP. Risk factors in interface epithelialization after laser in situ keratomileusis. J. Refract. Surg.20, 343–348 (2004).
   PubMed Web of Science ®Google Scholar
• Cobo-Soriano R, Beltran J, Baviera J. LASIK outcomes in patients with underlying systemic conditions. Ophthalmology113, 1118–1124 (2006).
   PubMed Web of Science ®Google Scholar
• Ghanbari H, Ahmadieh H. Aggravation of proliferative diabetic retinopathy after laser in situ keratomileusis. J. Cataract Refract. Surg.29, 2232–2233 (2003).
   PubMedGoogle Scholar
• Halkiadakis I, Belfair N, Gimbel HV. Laser in situ keratomileusis in patients with diabetes. J. Cataract Refract. Surg.31, 1895–1898 (2005).
   PubMedGoogle Scholar
• Eichenbaum JW, Feldstein M, Podos SM. Extended-wear aphakic soft contact lenses and corneal ulcers. Br. J. Ophthal.66, 663–666 (1982).
   PubMed Web of Science ®Google Scholar
• Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses a case–control study. N. Engl. J. Med.321, 773–778 (1989).
   PubMed Web of Science ®Google Scholar
• Spoor TC, Hartel WC, Wynn P, Spoor DK. Complications of continuous-wear soft contact lenses and corneal ulcers. Br. J. Ophthamol.102, 1312–1313 (1984).
   Google Scholar
• Herse PR. Recovery from contact lens-induced edema is prolonged in the diabetic rabbit cornea. Optom. Vis. Sci.67, 466–470 (1990).
   PubMed Web of Science ®Google Scholar
• Skaff A, Cullin AP, Doughty MJ, Fonn D. Corneal swelling and recovery following wear of thick hydrogel contact lenses in insulin-dependent diabetics. Ophthal. Physiol. Opt.15, 287–297 (1995).
   PubMed Web of Science ®Google Scholar
• Weston BC, Bourne WM, Polse KA, Hodge DO. Corneal hydration control in diabetes mellitus. Invest. Ophthalmol. Vis. Sci.36, 586–595 (1995).
   PubMed Web of Science ®Google Scholar
• McNamara NA, Brand RJ, Polse KA, Bourne WM. Corneal function during normal and high serum glucose levels in diabetics. Invest. Ophthalmol. Vis. Sci.39, 3–17 (1998).
   PubMed Web of Science ®Google Scholar
• O’Donnell C, Efron N, Boulton AJM. A prospective study of contact lens wear in diabetes mellitus. Ophthal. Physiol. Opt.21(2), 127–138 (2001).
   PubMed Web of Science ®Google Scholar
• March W, Long B, Hofmann W, Keys D, McKenney C. Safety of contact lenses in patients with diabetes. Diabetes Technol. Ther.6(1), 49–52 (2004).
   PubMedGoogle Scholar
• Fialho SA. The iris in diabetes. Int. Ophthalmol. Clin.3(3), 609–616 (1963).
   PubMedGoogle Scholar
• Gartner S, Henkind P. Neovascularization of the iris (rubeosis iridis). Surv. Ophthalmol.22, 291–312 (1978).
   PubMed Web of Science ®Google Scholar
• Pavan PR, Folk JC. Anterior Neovascularization. Int. Ophthalmol. Clin.24(4), 61–70 (1984).
   PubMedGoogle Scholar
• Cavallerano JD. A review of non-retinal ocular complications of diabetes mellitus. J. Am. Optom. Assoc.61(7), 533–543 (1991).
   Google Scholar
• L’Esperance FA, James WA. The eye and diabetes mellitus. In: Diabetes Mellitus: Theory and Practice. Ellenberg M, Rifkin H (Eds). Medical Examination Publishing, New York, NY, USA, 727–758 (1983).
   Google Scholar
• Smith SA, Smith SE. Evidence for a neuropathic aetiology in the small pupil of diabetes mellitus. Br. J. Ophthalmol.67, 89–93 (1983).
   PubMed Web of Science ®Google Scholar
• Zaczek A, Zetterstrom C. Cataract surgery and pupil size in patient with diabetes mellitus. Acta Ophthalmol. Scand.75, 429–432 (1997).
   PubMedGoogle Scholar
• Huber MJ, Smith SA, Smith SE. Mydriatic drugs for the diabetic patients. Br. J. Ophthalmol.69, 425–427 (1985).
   PubMed Web of Science ®Google Scholar
• Hreidarsson AB. Pupil motility in long-term diabetes. Diabetologia17, 145–150 (1979).
   PubMed Web of Science ®Google Scholar
• Bremner FD, Smith SE. Pupil abnormalities in selected autonomic neuropathies. J. Neuroophthalmol.26(3), 209–219 (2006).
   PubMedGoogle Scholar
• Ishikawa S, Bensaoula Y, Uga S et al. Electron microscopic study of iris nerves and muscles in diabetes. Ophthalmologica191, 172–183 (1985).
   PubMed Web of Science ®Google Scholar
• Moore RF. Diabetes in relation to diseases of the eye. Trans. Ophthalmol. Soc. UK49, 15 (1920).
   Google Scholar
• Spalding FM, Curtis WS. Retinitis and other changes in the eye of diabetics. Med. Surg. J.197, 165 (1927).
   Google Scholar
• Rothova A, Meenken C, Michels RPJ, Kijlstra A. Uveitis and diabetes mellitus. Am. J. Ophthalmol.106, 17–20 (1988).
   PubMed Web of Science ®Google Scholar
• Guy RJC, Richards F, Edmonds ME, Watkins PJ. Diabetic autonomic neuropathy and iritis. Br. Med. J.289, 343 (1984).
   PubMedGoogle Scholar
• Duke-Elder WS. Changes in refraction in diabetes mellitus. Br. J. Ophthalmol.9, 167–187 (1925).
   PubMedGoogle Scholar
• Gwinup G, Villarreal A. Relationship of serum glucose concentration to changes in refraction. Diabetes25, 29–21 (1976).
   PubMed Web of Science ®Google Scholar
• Marmor MF. Transient accommodative paralysis and hyperopia in diabetes. Arch. Ophthalmol.89, 418–421 (1973).
   Google Scholar
• Okamoto F, Sone H, Nonoyama T, Hommura S. Refractive changes in diabetic patients during intensive glycaemic control. Br. J. Ophthalmol.84, 1097–1102 (2000).
   PubMed Web of Science ®Google Scholar
• Tai MC, Lin SY, Chen JT, Liang CM, Chou PI, Lu DW. Sweet hyperopia: refractive changes in acute hyperglycemia. Eur. J. Ophthalmol.16(5), 663–666 (2006).
   PubMed Web of Science ®Google Scholar
• Riordan Eva P, Pascoe PT, Vaughan DG. Refractive change in hyperglycaemia: hyperopia, not myopia. Br. J. Ophthalmol.66, 500–505 (1982).
   PubMedGoogle Scholar
• Wiemer NGM, Dubbelman M, Kostense PJ, Ringens PJ, Polak BCP. The influence of chronic diabetes mellitus on the thickness and the shape of the anterior and posterior surface of the cornea. Cornea26(10), 1165–1170 (2007).
   PubMedGoogle Scholar
• Moss SE, Klein R, Klein BEK. Accommodative ability in younger-onset diabetes. Arch. Ophthalmol.105(4), 508–512 (1987).
   PubMed Web of Science ®Google Scholar
• Rogell GD. Internal opthalmoplegia after argon laser panretinal photocoagulation. Arch. Ophthalmol.97, 904–905 (1979).
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Moss SE. Prevalence of cataract in a population-based study of persons with diabetes mellitus. Ophthalmology92, 1191–1196 (1985).
   PubMed Web of Science ®Google Scholar
• Ederer F, Hiler R, Taylor HR. Senile lens changes and diabetes in two population studies. Am. J. Ophthalmol.91, 381–395 (1981).
   PubMed Web of Science ®Google Scholar
• Rowe N, Mitchell P, Cumming RG, Wang JJ. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol.7(2), 103–114 (2000).
   PubMedGoogle Scholar
• Klein BEK, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and the progression of lens opacities: the Beaver Dam Eye Study. Am. J. Ophthalmol.126, 782–790 (1998).
   PubMed Web of Science ®Google Scholar
• Mukesh BN, Anhchuong LE, Dimitrov PN, Taylor HR, McCarty CA. Development of cataract and associated risk factors: the Visual Impairment Project. Arch. Ophthalmol.124, 79–85 (2006).
   PubMedGoogle Scholar
• Leske MC, Chylack LT Jr, Wu SY. The lens opacities case–control study. Risk factors for cataract. Arch. Ophthalmol.109, 244–251 (1991).
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am. J. Epidemiol.124, 916–925 (1986).
   PubMed Web of Science ®Google Scholar
• Prchal J, Skalka H, Clements RS, Bradley EL, Conrad ME, Pittman C. Diabetes and risk of cataract development. Metab. Pediatr. Ophthalmol.4, 185–190 (1980).
   PubMedGoogle Scholar
• Miglior S, Marighi PE, Musico M, Balestreri C, Nicholosi A, Orzalesi N. Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case–control study. Ophthalmic Epidmiol.1, 93–105 (1994).
   PubMedGoogle Scholar
• Klein BEK, Klein R, Wang Q, Moss SE. Older-onset diabetes and lens opacities: the Beaver Dam Eye Study. Ophthalmic Epidemiol.2, 49–55 (1995).
   PubMedGoogle Scholar
• McCarty CA, Mukesh BN, Fu CL, Taylor HR. The epidemiology of cataract in Australia. Am. J. Ophthalmol.128(4), 446–465 (1999).
   PubMed Web of Science ®Google Scholar
• Saxena S, Mitchell P, Rochtchina E. Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiol.11(4), 271–277 (2004).
   PubMed Web of Science ®Google Scholar
• Negahban K, Chern K. Cataracts associated with systemic disorders and syndromes. Curr. Opin. Ophthalmol.13, 419–422 (2002).
   PubMedGoogle Scholar
• Datta V, Swift PGF, Woodruff GHA, Harris RF. Metabolic cataracts in newly diagnosed diabetics. Arch. Dis. Child.67, 118–120 (1997).
   Google Scholar
• Vinding T, Nielson NV. Two cases of acutely developed cataract in diabetes mellitus. Acta Ophthalmol.62(3), 373–377 (1984).
   Google Scholar
• Trindade F. Transient cataract and hypermetopization in diabetes mellitus. Arg. Bras. Oftalmol.70(6), 1037–1039 (2007).
   PubMedGoogle Scholar
• Sharma P, Vasavada AR. Acute transient bilateral diabetic posterior subcapsular cataracts. J. Cataract Refract. Surg.27, 789–794 (2001).
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am. J. Ophthalmol.119, 295–300 (1995).
   PubMed Web of Science ®Google Scholar
• Panchapakesan J, Cumming RG, Mitchell P. Reproducibility of the Wisconsin cataract grading system in the Blue Mountains Eye Study. Ophthalm. Epdiemiol.4, 119–126 (1997).
   PubMedGoogle Scholar
• Aiello LM, Wand M, Liang G. Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus. Ophthalmology90, 814–820 (1983).
   PubMed Web of Science ®Google Scholar
• Dowler JGF, Hykin PG, Lightman SL, Hamilton AM. Visual acuity following extracapsular cataract extraction in diabetes. Eye9, 313–317 (1995).
   PubMed Web of Science ®Google Scholar
• Kodoma T, Hayasaka S, Setogawa T. Plasma glucose levels, postoperative complications, and progression of retinopathy in diabetic patients undergoing intraocular lens implantation. Graefes Arch. Clin. Exp. Ophthalmol.231, 439–443 (1993).
   PubMedGoogle Scholar
• Chew EY, Benson WE, Remaley NA et al. Results after lens extraction in patients with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study report number 25. Arch. Ophthalmol.117, 1600–1606 (1999).
   PubMedGoogle Scholar
• Suto C, Hori S, Kato S. Management of Type 2 diabetics requiring panretinal photocoagulation and cataract surgery. J. Cataract Refract. Surg.34, 1001–1006 (2008).
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Burton TC. Progression of nonproliferative diabetic retinopathy following cataract extraction. Arch. Ophthalmol.106, 745–749 (1988).
   PubMedGoogle Scholar
• Pollack A, Dotan S, Oliver M. Course of diabetic retinopathy following cataract surgery. Br. J. Ophthalmol.75, 2–8 (1991).
   PubMedGoogle Scholar
• Pollack A, Dotan S, Oliver M. Progression of diabetic retinopathy after cataract extraction. Br. J. Ophthalmol.75, 547–551 (1991).
   PubMed Web of Science ®Google Scholar
• Hong T, Mitchell P, de Loryn T et al. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery. Ophthalmology116, 1510–1514 (2009).
   PubMed Web of Science ®Google Scholar
• Krepler K, Biowski R, Schrey S et al. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch. Clin. Exp. Ophthalmol.240, 735–738 (2002).
   PubMed Web of Science ®Google Scholar
• Squirrell D, Bhola R, Bush J et al. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with Type 2 diabetes. Br. J. Ophthalmol.86, 565–571 (2002).
   PubMed Web of Science ®Google Scholar
• Romero-Aroca P, Fernandez-Ballart J, Almena-Garcia M et al. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study. J. Cataract Refract. Surg.32, 1438–1444 (2006).
   PubMed Web of Science ®Google Scholar
• Biró Z, Balla Z. OCT measurements on the foveal and perifoveal retinal thickness on diabetic patients after phacoemulsification and IOL implantation. Eye (Lond.)24(4), 639–647 (2010).
   PubMedGoogle Scholar
• Dowler JG, Hykin PG, Hamilton AM. Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Ophthalmology107(3), 457–462 (2000).
   PubMedGoogle Scholar
• Zaczek A, Zetterstrom C. Posterior capsule opacification after phacoemulsification in patients with diabetes mellitus. J. Cataract Refract. Surg.25, 233–237 (1998).
   Google Scholar
• Shah AS, Chen SH. Cataract surgery and diabetes. Curr. Opin. Ophthalmol.21, 4–9 (2010).
   PubMed Web of Science ®Google Scholar
• Cheema RA, Al-Mubarak MM, Amin YM et al. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. J. Cataract Refract. Surg.35, 18–25 (2009).
   PubMed Web of Science ®Google Scholar
• Chen CH, Liu YC, Wu PC. The combination of intravitreal bevacizumab and phacoemulsification surgery in patients with cataract and coexisting diabetic macular edema. J. Ocul. Pharmacol. Ther.25, 83–89 (2009).
   PubMed Web of Science ®Google Scholar
• Lanzagorta-Aresti A, Palacios-Pozo E, Menezo Rozalen JL et al. Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: a pilot study. Retina29, 530–535 (2009).
   PubMed Web of Science ®Google Scholar
• Takamura Y, Kubo E, Akagi Y. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Ophthalmology116, 1151–1157 (2009).
   PubMed Web of Science ®Google Scholar
• Beck RW, Edwards AR, Aiello LP et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch. Ophthalmol.127, 245–251 (2009).
   PubMed Web of Science ®Google Scholar
• Hayashi M, Yablonski ME, Boxrud C, Fong N, Berger C, Jovanovic LJ. Decreased formation of aqueous humour in insulin-depended diabetic patients. Br. J. Ophthalmol.73(8), 621–623 (1989).
   PubMedGoogle Scholar
• Auricchio G, Diotallevi M. Relations between insulin therapy and aqueous humor production in diabetics. Graefes Arch. Ophthalmol.168, 85–89 (1965).
   PubMedGoogle Scholar
• Larsson L, Pach JM, Brubaker RF. Aqeuous humor dynamics in patients with diabetes mellitus. Am. J. Ophthalmol.120(3), 362–367 (1995).
   PubMedGoogle Scholar
• Hartnett ME, Tinkham N, Paynter L et al. Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am. J. Ophthalmol.148(6), 895–901.e1 (2009).
   PubMedGoogle Scholar
• Fahmy JA. Endophthalmitis following cataract extraction: a study of 24 cases in 4498 operations. Acta Ophthalmol.53, 522–536 (1975).
   Google Scholar
• Montan PG, Koranyi G, Setterquist HE, Stridh A, Philipson BT, Wiklund K. Endophthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history. Ophthalmology105(12), 2171–2177 (1998).
   PubMed Web of Science ®Google Scholar
• Phillips WB II, Tasman WS. Postoperative endophthalmitis in association with diabetes mellitus. Ophthalmology101, 508–518 (1994).
   PubMed Web of Science ®Google Scholar
• Scott IU, Flynn HW Jr, Feuer W. Endophthalmitis after secondary intraocular lens implantation: a case reports study. Ophthalmology102(12), 1925–1931 (1995).
   PubMed Web of Science ®Google Scholar
• Kattan HM, Flynn HW Jr, Pfugfelder SC, Robertson C, Forster RK. Nosocomial endophthalmitis study. Current incidence of infection after intraocular surgery. Ophthalmology98(8), 227–238 (1991).
   PubMed Web of Science ®Google Scholar
• Cohen SM, Flynn HW Jr, Murray TG, Smiddy WE. Endophthalmitis after pars plana vitrectomy. The Postvitrectomy Endophthalmitis Study Group. Ophthalmology102(5), 705–712 (1995).
   PubMed Web of Science ®Google Scholar
• Liao HR, Lee HW, Leu HS, Lin BJ, Juang CJ. Endogenous Klebsiella pneumonia endophthalmitis in diabetic patients. Can. J. Ophthalmol.27(3), 143–147 (1992).
   PubMed Web of Science ®Google Scholar
• Walmsley RS, David DB, Allan RN, Kirkby GR. Bilateral endogenous Escherichia coli endophthalmitis: a devastating complication in an insulin-dependent diabetic. Postgrad. Med. J.72, 361–363 (1996).
   PubMedGoogle Scholar
• Park SB, Searl S, Aquavella JV, Erdey RA. Endogenous endopthalmitis caused by Eschericia coli. Ann. Ophthalmol.25, 95–99 (1993).
   PubMedGoogle Scholar
• Sebag J, Buckingham G, Charles MA et al. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch. Ophthalmol.110, 1472–1476 (1992).
   PubMed Web of Science ®Google Scholar
• Foos RY, Krieger AE, Forsythe AV. Posterior vitreous detachment in diabetic subjects. Ophthalmology87, 122–128 (1980).
   PubMed Web of Science ®Google Scholar
• Tagawa H, McMeel JW, Furukawa H. Role of the vitreous in diabetic retinopathy. I. vitreous changes in diabetic retinopathy and in physiologic aging. Ophthalmology93, 596–601 (1986).
   PubMed Web of Science ®Google Scholar
• Sebag J. Abnormalities of human vitreous structure in diabetes. Graefe’s Arch. Clin. Exp. Ophth.231, 257–260 (1993).
   PubMed Web of Science ®Google Scholar
• Sebag J. Diabetic vitreopathy. Ophthalmol.103, 205–206 (1996).
   PubMed Web of Science ®Google Scholar
• Faulborn J, Bowald S. Microproliferations in proliferative diabetic retinopathy and their relation to the vitreous – corresponding light and electron microscopic study. Graefe’s Arch. Clin. Exp. Ophthalmol.1223, 130–138 (1985).
   Google Scholar
• Sebag J. The Vitreous – Structure, Function, and Pathobiology. Springer-Verlag, NY, USA (1989).
   Google Scholar
• Bergen RL, Brown GC, Duker JS. Prevalence and association of asteroid hyalosis with systemic diseases. Am. J. Ophthalmol.111, 289–293 (1991).
   Google Scholar
• Yazar Z, Hanioglu S, Karakoc G, Gursel E. Asteroid hyalosis. Eur. J. Ophthalmol.11, 57–61 (2001).
   PubMed Web of Science ®Google Scholar
• Mitchell P, Wang MY, Wang JJ. Asteroid hyalosis in an older population: the Blue Mountains Eye Study. Ophthalmic Epidemiol.10, 331–335 (2003).
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Asteroid hyalosis in a population: the Beaver Dam eye study. Am. J. Ophthalmol.132, 70–75 (2001).
   PubMed Web of Science ®Google Scholar
• Fawzi AA, Vo B, Kriwanek R et al. Asteroid hyalosis in an autopsy population: the University of California at Los Angeles (UCLA) experience. Arch. Ophthalmol.123, 486–490 (2005).
   PubMedGoogle Scholar
• Kador PF, Wyman M. Asteroid hyalosis: pathogenesis and prospects for prevention. Eye22, 1278–1285 (2008).
   PubMed Web of Science ®Google Scholar
• Schwartz JN, Donnelly EH, Klintworth GK. Ocular and orbital phycomycosis. Surv. Ophthalmol.22, 3–28 (1977).
   PubMedGoogle Scholar
• Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbito-cerebral mucormycosis. Surv. Ophthalmol.39, 3–22 (1994).
   PubMed Web of Science ®Google Scholar
• Lee BL, Holland GN, Glasgow BJ. Chiasmal infarction and sudden blindness caused by mucormycosis in AIDS and diabetes mellitus. Am. J. Ophthalmol.122, 895–896 (1996).
   PubMed Web of Science ®Google Scholar
• Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope90, 635–648 (1980).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care15, 1875–1891 (1992).
   PubMed Web of Science ®Google Scholar
• Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res. Clin. Pract.74, 301–308 (2006).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Ophthalmol.102, 527–532 (1984).
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology105, 406–411 (1998).
   PubMed Web of Science ®Google Scholar
• Klein R, Lee KE, Gangnon RE, Klein BEK. The 25-year incidence of visual impairment in Type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology117, 63–70 (2010).
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BEK. The twenty-five-year progression of retinopathy in persons with Type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII. Ophthalmology115, 1859–1868 (2008).
   PubMed Web of Science ®Google Scholar
• Stratton IM, Kohner EM, Aldington SJ et al. Risk factors for incidence and progression of retinopathy in Type 2 diabetes over 6 years from diagnosis: UKPDS 50. Diabetologia44, 156–163 (2001).
   PubMed Web of Science ®Google Scholar
• Van Leiden HA, Dekker JM, Moll AC et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn Study. Arch. Ophthalmol.121, 245–251 (2003).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol.102, 520–526 (1984).
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Ocular factors in the incidence and progression of diabetic retinopathy. Ophthalmology101, 77–83 (1994).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch. Intern. Med.157, 650–656 (1997).
   PubMedGoogle Scholar
• Rabb MF, Gagliano DA, Sweeney HE. Diabetic retinopathy in blacks. Diabetes Care13, 1202–1206 (1990).
   PubMed Web of Science ®Google Scholar
• Eliasson B. Cigarette smoking and diabetes. Prog. Cardiovasc. Dis.45, 405–413 (2003).
   PubMed Web of Science ®Google Scholar
• Xie XT, Liu Q, Wu J, Wakui M. Impact of cigarette smoking in Type 2 diabetes development. Acta Pharmacol. Sin.30, 784–787 (2009).
   PubMed Web of Science ®Google Scholar
• Hur NW, Kim HC, Nam CM, Jee SH, Lee HC, Suh I. Smoking cessation and risk of Type 2 diabetes mellitus: Korea medical Insurance Corporation Study. Eur. J. Cardiovasc. Prev. Rehabil.14, 244–249 (2007).
   PubMedGoogle Scholar
• Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for Type 2 diabetes mellitus: a cohort study. Ann. Intern. Med.152, 10–17 (2010).
   PubMed Web of Science ®Google Scholar
• Dibble CM, Kochenour NK, Worley RJ, Tyler FH, Swartz M. Effect of pregnancy on diabetic retinopathy. Obstet. Gynecol.59, 699–704 (1982).
   PubMed Web of Science ®Google Scholar
• Rahman W, Rahman FZ, Yassin S, Al-Suleiman SA, Rahman J. Progression of retinopathy during pregnancy in Type 1 diabetes mellitus. Clin. Experiment. Ophthalmol.35, 231–236 (2007).
   PubMedGoogle Scholar
• Horvat M, MaClean H, Goldberg L, Crock GW. Diabetic retinopathy in pregnancy: a 12-year prospective survey. Br. J. Ophthalmol.64, 398–403 (1980).
   PubMed Web of Science ®Google Scholar
• Arar NH, Freedman BI, Adler SG. Heritability of the severity of diabetic retinopathy: the FIND-Eye Study. Invest. Ophthalmol. Vis. Sci.49, 3839–3845 (2008).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care15, 1875–1891 (1992).
   PubMed Web of Science ®Google Scholar
• Pedro RA, Isabel MM, Marc BB, Juan FB, Ester SB. Review of the relationship between renal and retinal microangiopathy in diabetes mellitus patients. Curr. Diabetes Rev. (2009) (Epub ahead of print).
   Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.329, 977–986 (1993).
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes: UKPDS 33. Lancet352, 837–853 (1998).
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with Type 2 diabetes: UKPDS 34. Lancet352, 854–865 (1998).
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS Report 9. Ophthalmology98, 766–785 (1991).
   PubMed Web of Science ®Google Scholar
• Nunes S, Pires I, Rosa A, Duarte L, Bernardes R, Cunha-Vaz J. Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for Type 2 diabetics with nonproliferative retinopathy. Ophthalmologica223, 292–297 (2009).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Linton KL. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology99, 58–62 (1992).
   PubMed Web of Science ®Google Scholar
• Ferris F. Early photocoagulation in patients with either Type 1 or Type 2 diabetes. Trans. Am. Ophthalmol. Soc.94, 505–537 (1996).
   PubMedGoogle Scholar
• The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy clinical application of Diabetic Retinopathy Study (DRS) findings: DRS report 8. Ophthalmology88, 583–600 (1981).
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial: Report 2. Arch. Ophthalmol.103, 1644–1652 (1985).
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Report 5. Arch. Ophthalmol.108, 958–964 (1990).
   PubMedGoogle Scholar
• Ishida S, Usui T, Yamashiro K et al. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J. Exp. Med.198, 483–489 (2003).
   PubMed Web of Science ®Google Scholar
• Simo R, Hernandez C. Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia51, 1574–1580 (2008).
   PubMed Web of Science ®Google Scholar
• Avery RL, Pearlman J, Pieramici DJ et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology113, 1695–1705 (2006).
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liang X, Li X, Tao Y, Wang K. Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy. Acta Ophthalmol.87, 736–740 (2008).
   PubMedGoogle Scholar
• Tonello M, Costa RA, Almeida FPP et al. Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol.86, 385–389 (2008).
   PubMed Web of Science ®Google Scholar
• Mishashi A, Roohiport R, Lashay A et al. Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial. Eur. J. Ophthalmol.18, 263–269 (2008).
   PubMedGoogle Scholar
• Mason JO, Yunker JJ, Vail R, McGwin G Jr. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy. Retina28, 1319–1324 (2008).
   PubMedGoogle Scholar
• Mordenti J, Cuthbertson RA, Ferrara N et al. Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled and Fab antibodies in the rhesus monkey after intravitreal administration. Toxicol. Pathol.27, 536–544 (1999).
   PubMed Web of Science ®Google Scholar
• Chun DW, Heier JS, Topping TM et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant macular edema. Ophthalmology113, 1706–1712 (2006).
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Tatlipinar S, Shah SM et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am. J. Ophthalmol.142, 961–969 (2006).
   PubMed Web of Science ®Google Scholar
• Raman R, Rani PK, Kulothungan V, Rachepalle SR, Kumaramanickavel G, Sharma T. Influence of serum lipids on clinically significant versus nonclinically significant macular edema: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study Report 13. BMC Ophthalmol.117(4), 766–772 (2010).
   Google Scholar
• Chew EY, Klein ML, Ferris FL et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch. Ophthalmol.114, 1079–1084 (1996).
   PubMed Web of Science ®Google Scholar
• Klein BE, Moss SE, Klein R, Surawicz TS. Relationship of serum cholesterol to retinopathy and hard exudate: the Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII. Ophthalmology98, 1261–1065 (1991).
   PubMed Web of Science ®Google Scholar
• Chew EY. Diabetic retinopathy and lipid abnormalities. Curr. Opin. Ophthalmol.8, 59–62 (1997).
   PubMedGoogle Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: Report 2. Ophthalmology94, 761–774 (1987).
   PubMed Web of Science ®Google Scholar
• Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Retina30(2), 254–259 (2010).
   PubMed Web of Science ®Google Scholar
• Yilmaz T, Weaver CD, Gallagher MJ. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systemic review. Ophthalmology116, 912–913 (2009).
   Google Scholar
• Koleva-Georgieva D, Sivkova N. Assessment of serous macular detachment in eyes with diabetic macular edema by use of spectral domain optical coherence tomography. Graefes Arch. Clin. Exp. Ophthalmol.247, 1461–1469 (2009).
   PubMedGoogle Scholar
• Packer AJ. Vitrectomy for progressive macular traction associated with proliferative diabetic retinopathy. Arch. Ophthalmol.105, 1679–1682 (1987).
   PubMedGoogle Scholar
• Kakehashi A, Trempe CL, Fujio N, McMeel JW, Schepens CL. Retinal breaks in diabetic retinopathy: vitreoretinal relationships. Ophthalmic Surg.25, 695–699 (1994).
   PubMedGoogle Scholar
• Meier P, Wiedemann P. Vitrectomy for traction macular detachment in diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol.235, 569–574 (1997).
   PubMedGoogle Scholar
• Mason J 3rd, Somaiya MD, White MF Jr, Vail RS. Macular holes associated with diabetic tractional retinal detachments. Ophthalmic Surg. Lasers Imaging39, 288–293 (2008).
   PubMedGoogle Scholar
• The Eye Disease Case–Control Study Group. Risk factors for central retinal vein occlusion. Arch. Ophthalmol.114, 545–554 (1996).
   PubMed Web of Science ®Google Scholar
• Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch. Ophthalmol.124, 726–732 (2006).
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am. J. Ophthalmol.131, 61–77 (2001).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans. Am. Ophthalmol. Soc.98, 133–143 (2000).
   PubMedGoogle Scholar
• Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology86, 1931–1942 (1979).
   PubMed Web of Science ®Google Scholar
• Little HL, Sacks A, Vassiliadis A, Greer R. Current concepts of pathogenesis of diabetic retinpathy: a dysproteinemia. Trans. Am. Ophthalmol. Soc.75, 397–426 (1977).
   PubMedGoogle Scholar
• Nagy V, Takacs L, Steiber Z, Pfliegler G, Berta A. Thrombophilic screening in retinal artery occlusion patients. Clin. Ophthalmol.2, 557–561 (2008).
   PubMedGoogle Scholar
• Ino-ue M, Azumi A, Kajiura-Tsukahara Y, Yamamoto M. Ocular ischemic syndrome in diabetic patients. Jpn. J. Ophthalmol.43, 31–35 (1999).
   PubMed Web of Science ®Google Scholar
• Chen KJ, Chen SN, Kao LY et al. Ocular ischemic syndrome. Chang Gung Med. J.24, 483–491 (2001).
   PubMedGoogle Scholar
• Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology104, 859–864 (1997).
   PubMed Web of Science ®Google Scholar
• Rayner S, Lee N, Leslie D, Thompson G. Lipaemia retinalis: a question of chylomicrons? Eye (Lond.)10, 603–608 (1996).
   PubMedGoogle Scholar
• Laws HW, Harpur ER. Lipemia retinalis; report of a case in a diabetic child aged twenty-eight months and review of the literature. AMA Arch. Ophthalmol.59, 521–526 (1958).
   PubMedGoogle Scholar
• Gopal L, Sunder KS, Rao SK, Soni M, Sharma S, Ramakrishnan S. Hyperlipidemia in a poorly controlled diabetic presenting with lipemic aqueous and lipemia retinalis. J. Retinal Vitreous Dis.24, 312–315 (2004).
   PubMedGoogle Scholar
• Slagle WS, Musick A, Eckermann D. Diabetic papillopathy and its relation to optic nerve ischemia. Optom. Vis. Sci.86, E395–E403 (2009).
   Web of Science ®Google Scholar
• Barr CC, Glaser JS, Blankenship G. Acute disc swelling in juvenile diabetes: clinical profile and natural history of 12 cases. Arch. Ophthalmol.98, 2185–2192 (1980).
   PubMedGoogle Scholar
• Lubow M, Makley TA Jr. Pseudopapilledema of juvenile diabetes mellitus. Arch. Ophthalmol.85, 417–422 (1971).
   PubMedGoogle Scholar
• Appen RE, Chandra SR, Klein R et al. Diabetic papillopathy. Am. J. Ophthalmol.90, 203–209 (1980).
   PubMedGoogle Scholar
• Pavan PR, Aiello LM, Wafai MZ et al. Optic disc edema in juvenile-onset diabetes. Arch. Ophthalmol.98, 2193–2195 (1980).
   PubMedGoogle Scholar
• Regillo CD, Brown GC, Savino PJ et al. Diabetic papillopathy. Patient characteristics and fundus findings. Arch. Ophthalmol.113, 889–895 (1995).
   PubMedGoogle Scholar
• Friedrich Y, Feiner M, Gawi H, Friedman Z. Diabetic papillopathy with macular star mimicking clinically significant diabetic macular edema. Retina21, 80–82 (2001).
   PubMedGoogle Scholar
• Jeganathan VS, Wang JJ, Wong TY. Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care31, 1905–1912 (2008).
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic versus nondiabetic patients. Ophthalmology115, 1818–1825 (2008).
   PubMed Web of Science ®Google Scholar
• Arnold A. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J. Neuro. Opthalmol.23, 157–163 (2003).
   PubMed Web of Science ®Google Scholar
• Optic Neuropathy Decompression Trial Study Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial. Arch. Ophthalmol.114, 1366–1374 (1996).
   PubMed Web of Science ®Google Scholar
• Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case–control study of potential risk factors. Arch. Ophthalmol.115, 1403–1407 (1997).
   PubMedGoogle Scholar
• Salomon O, Huna-Baron R, Kurtz S et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology106, 739–742 (1999).
   PubMed Web of Science ®Google Scholar
• Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology91, 1334–1337 (1984).
   PubMed Web of Science ®Google Scholar
• Feit RH, Tomsak RL, Ellenberger C Jr. Structural factors in the pathogenesis of ischemic optic neuropathy. Am. J. Ophthalmol.98, 105–108 (1984).
   PubMed Web of Science ®Google Scholar
• Doro S, Lessell S. Cup–disc ratio and ischemic optic neuropathy. Arch. Ophthalmol.103, 1143–1144 (1985).
   PubMedGoogle Scholar
• Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology94, 1503–1508 (1987).
   PubMed Web of Science ®Google Scholar
• Mansour AM, Shoch D, Logani S. Optic disk size in ischemic optic neuropathy. Am. J. Ophthalmol.106, 587–589 (1988).
   PubMed Web of Science ®Google Scholar
• Ischemic Optic Neuropathy Decompression Trial Research Group. Ischemic Optic Neuropathy Decompression Trial: twenty-four month update. Arch. Ophthalmol.118, 793–798 (2000).
   PubMedGoogle Scholar
• Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy is not effective and may be harmful. JAMA273, 625–632 (1995).
   PubMed Web of Science ®Google Scholar
• Kupersmith MJ, Frohman L, Sanderson M et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J. Neuro-Opthalmol.17, 250–253 (1997).
   PubMed Web of Science ®Google Scholar
• Yoles E, Wheeler LA, Schwartz M. α2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest. Opthalmol. Vis. Sci.40, 65–73 (1999).
   PubMed Web of Science ®Google Scholar
• Quigley HA. Number of people with glaucoma worldwide. Br. J. Ophthalmol.80, 389–393 (1996).
   PubMed Web of Science ®Google Scholar
• Sahin A, Bayer A, Ozge G, Mumcuoglu T. Corneal biomechanical changes in diabetes mellitus and their influence on intraocular pressure measurements. Invest. Ophthalmol. Vis. Sci.50, 4597–4604 (2009).
   PubMed Web of Science ®Google Scholar
• Tan GS, Wong TY, Fong CW, Aung T. Diabetes, metabolic abnormalities, and glaucoma: the Singapore Malay Eye Study. Arch. Ophthalmol.127, 1354–1361 (2009).
   PubMedGoogle Scholar
• Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology102, 48–53 (1995).
   PubMed Web of Science ®Google Scholar
• Xu L, Wang YX, Jonas JB, Wang YS, Wang S. Ocular hypertension and diabetes mellitus in the Beijing Eye Study. J. Glaucoma.18, 21–25 (2009).
   PubMed Web of Science ®Google Scholar
• Hennis A, Wu SY, Nemesure B, Leske MC. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology110, 908–914 (2003).
   PubMed Web of Science ®Google Scholar
• Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv. Ophthalmol.53, S3–S10 (2008).
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology101, 1173–1177 (1994).
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Chey T, Healey P. Open-angle glaucoma and diabetes: the Blue Mountain Eye Study, Australia. Ophthalmology104, 712–718 (1997).
   PubMed Web of Science ®Google Scholar
• Pasquale LR, Kang JH, Manson JE, Willett WC, Rosner BA, Hankinson SE. Prospective study of Type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology113, 1081–1086 (2006).
   PubMed Web of Science ®Google Scholar
• Chopra V, Varma R, Francis B et al. Type 2 diabetes mellitus and the risk of open-angle glaucoma: the Los Angeles Latino Eye Study. Ophthalmology115, 227–232 (2008).
   PubMed Web of Science ®Google Scholar
• Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet. Med.21, 609–614 (2004).
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am. J. Ophthalmol.134, 499–512 (2002).
   PubMed Web of Science ®Google Scholar
• Lichter PR, Musch DC, Gillespie BW et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology108, 1943–1953 (2001).
   PubMed Web of Science ®Google Scholar
• Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B; BESs Study Group. Risk factors for incidence of open-angle glaucoma. The Barbados Eye Studies. Ophthalmology115, 85–93 (2008).
   PubMed Web of Science ®Google Scholar
• Le A, Mukesh BN, McCarty CA, Taylor HR. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest. Ophthalmol. Vis. Sci.44, 3783–3739 (2003).
   PubMed Web of Science ®Google Scholar
• de Voogd S, Ikram MK, Wolfs RC et al. Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam Study. Ophthalmology113, 1827–1831 (2006).
   PubMed Web of Science ®Google Scholar
• Müskens RP, de Voogd S, Wolfs RC et al. Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology114, 2221–2226 (2007).
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch. Ophthalmol.120, 1268–1279 (2002).
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology106, 2144–2153 (1999).
   PubMed Web of Science ®Google Scholar
• Drance S, Anderson DR, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am. J. Ophthalmol.131, 699–708 (2001).
   PubMed Web of Science ®Google Scholar
• Kooner KS, Albdoor M, Cho BJ, Adams-Huet B. Risk factors for progression to blindness in high tension primary open angle glaucoma: comparison of blind and nonblind subjects. Clin. Ophthalmol.2, 757–762 (2008).
   PubMedGoogle Scholar
• Mapstone R, Clark CV. Prevalence of Type 2 diabetes in glaucoma. Br. Med. J.291, 93–95 (1985).
   PubMed Web of Science ®Google Scholar
• Brown GC, Magargal LE, Schachat A, Shah H. Neovascular glaucoma: etiologic considerations. Ophthalmology91, 315–320 (1984).
   PubMedGoogle Scholar
• Madsen PH. Experiences in surgical treatment of haemorrhagic glaucoma: a follow-up study. Acta Ophthalmol. Suppl.120, 88–91 (1973).
   PubMedGoogle Scholar
• Flammer J, Orgül S, Costa VP et al. The impact of ocular blood flow in glaucoma. Prog. Ret. Eye Res.21, 359–393 (2002).
   PubMed Web of Science ®Google Scholar
• Piltz-seymour JR, Grunwald JE, Hariprasad SM, Dupont J. Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am. J. Ophthalmol.132, 63–69 (2001).
   PubMed Web of Science ®Google Scholar
• Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin. Ophthalmol.24, 113–121 (2009).
   PubMed Web of Science ®Google Scholar
• Vasudev D, Blair MP, Galasso J, Kapur R, Vajaranant T. Intravitreal bevacizumab for neovascular glaucoma. J. Ocul. Pharmacol. Ther.25, 453–458 (2009).
   PubMed Web of Science ®Google Scholar
• Ganie MA, Bhat D. Current developments in wolfram syndrome. J. Pediatr. Endocrinol. Metab.22, 3–10 (2009).
   PubMedGoogle Scholar
• Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J. Med. Genet.34, 838–841 (1997).
   PubMed Web of Science ®Google Scholar
• Simsek E, Simsek T, Tekgul S et al. Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical in nine Turkish patients an review of the literature. Acta. Paediatr.92, 55–61 (2003).
   PubMed Web of Science ®Google Scholar
• Green WR, Hackett ER, Schlezinger NS. Neuroophthalmologic evaluation of oculomotor nerve paralysis. Arch. Ophthalmol.72, 154 (1964).
   PubMedGoogle Scholar
• Watanabe K, Hagura R, Akanuma Y et al. Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res. Clin. Pract.10(1), 19–27 (1990).
   PubMed Web of Science ®Google Scholar
• Trigler L, Siatkowski RM, Oster AS et al. Retinopathy in patients with diabetic ophthalmoplegia. Ophthalmology110, 1545–1550 (2003).
   PubMedGoogle Scholar
• Shrader EC, Schlezinger NS. Neuroophthalmologicc evaluation of abducens nerve paralysis. Arch. Ophthalmol.63, 84 (1960).
   PubMedGoogle Scholar
• Chauhan S. Simultaneous bilateral oculomotor nerve paralysis: an unusual manifestation of diabetes mellitus. Singapore Med. J.47(11), 1006 (2006).
   PubMedGoogle Scholar
• Eshbaugh CG, Siatkowski RM, Smith JL, Kline LB. Simultaneous, multiple cranial neuropathies in diabetes mellitus. J. Neuro-Ophthalmol.15(4), 219–224 (1995).
   PubMed Web of Science ®Google Scholar
• Richards BW, Jones FR, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am. J. Opthalmol.113(5), 489–496 (1992).
   PubMed Web of Science ®Google Scholar
• Bianchi-Marzoli S, Brancato R. Third, fourth and sixth cranial nerve palsies. Curr. Opin. Ophthalmol.8, 45–51 (1997).
   PubMedGoogle Scholar
• Tracy JA, Dyck PJB. The spectrum of diabetic neuropathies. Phys. Med. Rehabil. Clin. N. Am.19, 1–26 (2009).
   Google Scholar
• Tankova T, Cherninkova S, Koev D. Treatment for diabetic mononeuropathy with α-lipoic acid. Int. J. Clin. Pract.59(6), 645–650 (2005).
   PubMedGoogle Scholar
• Jacobson DM. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch. Ophthalmol.116, 723–727 (1998).
   PubMedGoogle Scholar
• Trobe JD. Managing oculomotor nerve palsy. Arch. Ophthalmol.116, 798 (1998).
   PubMedGoogle Scholar
• Gilhotra JS, Mitchell P, Healey P, Cumming RG, Currie J. Homonymous field defects and stroke in an older population. Stroke33, 2417–2420 (2002).
   PubMed Web of Science ®Google Scholar
• Warlow CP. Epidemiology of stroke. Lancet352(Suppl. III), 1–4 (1998).
   PubMed Web of Science ®Google Scholar
• Thompson DW, Furlan AJ. Clinical epidemiology of stroke. Neurol. Clin.14, 309–315 (1996).
   PubMedGoogle Scholar
• Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke22, 312–318 (1991).
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology98, 786–806 (1991).
   PubMed Web of Science ®Google Scholar
• Negi A, Vernon SA. An overview of the eye in diabetes. J. R. Soc. Med.96, 266–272 (2003).
   PubMed Web of Science ®Google Scholar
• The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease, (5th Edition). Ehlers J, Shah C (Eds). Lippincott Williams and Wilkins, PA, USA (2008).
   Google Scholar
• Al-Haddad CE, Jurdi FA, Bashshur ZF. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am. J. Ophthalmol.137, 1151–1153 (2004).
   PubMedGoogle Scholar